Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza

Clinical Infectious Diseases

Volumn 57, Issue 2, 2013, Pages 167-175

  Castilla, Jesús ^a,b   Godoy, Pere ^b,c   Domínguez, Ángela ^b,d   Martínez Baz, Iván ^a,b   Astray, Jenaro ^e   Martín, Vicente ^b,f   Delgado Rodríguez, Miguel ^b,g   Baricot, Maretva ^b   Soldevila, Nuria ^b   Mayoral, José María ^h   Quintana, José María ^b,i   Galán, Juan Carlos ^b,j   Castro, Ady ^k   González Candelas, Fernando ^b,l   Garín, Olatz ^b,m   Saez, Marc ^b,n   Tamames, Sonia ^o   Pumarola, Tomás ^p  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Generalitat of Catalonia   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Área de Epidemiología ^*  (Spain)

^f UNIVERSITY OF LEÓN   (Spain)

^g UNIVERSITY OF JAÉN   (Spain)

^h Servicio de Vigilancia de Andalucia   (Spain)

ⁱ Hospital Galdakao Usansolo   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k INSTITUTO DE SALUD CARLOS III   (Spain)

^l UNIVERSITY OF VALENCIA   (Spain)

^m HOSPITAL DEL MAR   (Spain)

ⁿ UNIVERSITY OF GIRONA   (Spain)

^o Castile and León   (Spain)

^p Red Española de Investigación en Patología Infecciosa REIPI   (Spain)

more..

Author keywords

influenza vaccine; influenza virus; severe influenza; vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

INFLUENZA VACCINE; INFLUENZA VIRUS; SEVERE INFLUENZA; VACCINE EFFECTIVENESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; PREGNANCY; PROGNOSIS; SPAIN; YOUNG ADULT;

EID: 84879678274     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit194     Document Type: Article

References (30)

1. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4:25-44.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
3. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181:831-7.
4. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
5. Kissling E, Valenciano M, Cohen JM, et al. I-MOVE Multi-Centre Case Control Study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One 2011; 6:e27622.
6. Jiménez-Jorge S, Savulescu C, Pozo F, et al. Effectiveness of the 2010- 11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012; 30:3595-602.
7. Pelat C, Falchi A, Carrat F, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011; 6:e19621.
8. Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenanim J. Vaccine effectiveness in pandemic influenza-primary care reporting (VIPER): An observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 2010; 14: 313-6.
9. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79.
10. Pebody RG, Andrews N, Fleming DM, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2013; 141:620-30.
11. Fielding JE, Grant KA, Garcia K, Kelly HA. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011; 17:1181-7.
12. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011; 203:500-8.
13. Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ 2011; 344:d7901.
14. Hellenbrand W, Jorgensen P, Schweiger B, et al. Prospective hospitalbased case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls. BMC Infect Dis 2012; 12:127.
15. Cheng AC, Kotsimbos T, Kelly HA, et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A testnegative case control study. Vaccine 2011; 29:7320-5.
16. Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, casecontrol study. Vaccine 2012; 30:5714-20.
17. Castilla J, Martínez-Artola V, Salcedo E, et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012; 30:195-200.
18. Domínguez A, Castilla J, Godoy P, et al. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization. Vaccine 2012; 30:5644-50.
19. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. Clin Infect Dis 2009; 199:159-67.
20. Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008; 122:911-9.
21. Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011; 52:1203-11.
22. Szilagyi PG, Fairbrother G, Griffin MR, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: A case-cohort study. Arch Pediatr Adolesc Med 2008; 162:943-51.
23. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
24. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373-81.
25. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: An ongoing controversy. Lancet Infect Dis 2007; 7:658-66.
26. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35:337-44.
27. Sistema de vigilancia de la gripe en España. Vigilancia de la gripe en España, temporada 2010-2011 [in Spanish]. Instituto de Salud Carlos III. Available at: http://vgripe.isciii.es/gripe/documentos/20102011/ InformesAnuales/Informe-GRIPE-Temporada-2010-11-07092011.pdf. Accessed on 31 March 2013.
28. Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009; 27:6300-4.
29. Shieh WJ, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010; 177:166-75.
30. Palacios G, Horning M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009; 4:e8540.